Starpharma Holdings Ltd
ASX:SPL
Balance Sheet
Balance Sheet Decomposition
Starpharma Holdings Ltd
Current Assets | 39.5m |
Cash & Short-Term Investments | 32.1m |
Receivables | 4.7m |
Other Current Assets | 2.7m |
Non-Current Assets | 4.4m |
PP&E | 4.4m |
Current Liabilities | 7.1m |
Accounts Payable | 5m |
Accrued Liabilities | 1.3m |
Other Current Liabilities | 774k |
Non-Current Liabilities | 2.4m |
Long-Term Debt | 2.4m |
Other Non-Current Liabilities | 68k |
Balance Sheet
Starpharma Holdings Ltd
Jun-2014 | Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
24
|
31
|
46
|
61
|
51
|
41
|
30
|
61
|
50
|
35
|
|
Cash |
1
|
3
|
1
|
3
|
3
|
3
|
4
|
3
|
4
|
2
|
|
Cash Equivalents |
23
|
28
|
45
|
58
|
48
|
38
|
26
|
57
|
46
|
34
|
|
Total Receivables |
4
|
4
|
4
|
4
|
6
|
6
|
6
|
8
|
8
|
8
|
|
Accounts Receivables |
4
|
4
|
4
|
4
|
6
|
6
|
6
|
8
|
7
|
8
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
|
Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
3
|
3
|
|
Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
Total Current Assets |
29
|
35
|
50
|
66
|
57
|
48
|
37
|
71
|
61
|
47
|
|
PP&E Net |
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
6
|
5
|
|
PP&E Gross |
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
6
|
5
|
|
Accumulated Depreciation |
3
|
2
|
3
|
3
|
3
|
3
|
3
|
4
|
4
|
3
|
|
Intangible Assets |
6
|
6
|
6
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Goodwill |
2
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Assets |
2
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Assets |
37
N/A
|
44
+20%
|
59
+33%
|
67
+13%
|
59
-12%
|
49
-16%
|
39
-20%
|
73
+87%
|
66
-10%
|
52
-21%
|
|
Liabilities | |||||||||||
Accounts Payable |
3
|
6
|
9
|
5
|
4
|
5
|
4
|
8
|
8
|
8
|
|
Accrued Liabilities |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
|
Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Current Liabilities |
4
|
7
|
10
|
6
|
5
|
6
|
7
|
10
|
10
|
14
|
|
Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
7
|
3
|
|
Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Liabilities |
4
N/A
|
7
+75%
|
10
+41%
|
6
-42%
|
5
-7%
|
6
+24%
|
8
+20%
|
11
+41%
|
18
+63%
|
17
-3%
|
|
Equity | |||||||||||
Common Stock |
140
|
161
|
194
|
194
|
194
|
194
|
194
|
241
|
241
|
241
|
|
Retained Earnings |
107
|
124
|
145
|
133
|
140
|
151
|
162
|
178
|
192
|
206
|
|
Unrealized Security Profit/Loss |
2
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Equity |
3
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Equity |
33
N/A
|
38
+14%
|
49
+32%
|
61
+23%
|
53
-13%
|
42
-20%
|
31
-26%
|
62
+99%
|
48
-22%
|
35
-28%
|
|
Total Liabilities & Equity |
37
N/A
|
44
+20%
|
59
+33%
|
67
+13%
|
59
-12%
|
49
-16%
|
39
-20%
|
73
+87%
|
66
-10%
|
52
-21%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
285
|
319
|
367
|
369
|
371
|
372
|
373
|
406
|
408
|
410
|